HomeCompareTBLMF vs PFE

TBLMF vs PFE: Dividend Comparison 2026

TBLMF yields 13.61% · PFE yields 6.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 TBLMF wins by $3599876.35M in total portfolio value
10 years
TBLMF
TBLMF
● Live price
13.61%
Share price
$20.88
Annual div
$2.84
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$3599876.40M
Annual income
$3,549,766,669,631.37
Full TBLMF calculator →
PFE
Pfizer Inc.
● Live price
6.13%
Share price
$28.08
Annual div
$1.72
5Y div CAGR
13.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$49.6K
Annual income
$26,258.71
Full PFE calculator →

Portfolio growth — TBLMF vs PFE

📍 TBLMF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodTBLMFPFE
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, TBLMF + PFE cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
TBLMF pays
PFE pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

TBLMF
Annual income on $10K today (after 15% tax)
$1,156.74/yr
After 10yr DRIP, annual income (after tax)
$3,017,301,669,186.66/yr
PFE
Annual income on $10K today (after 15% tax)
$520.66/yr
After 10yr DRIP, annual income (after tax)
$22,319.90/yr
At 15% tax rate, TBLMF beats the other by $3,017,301,646,866.76/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of TBLMF + PFE for your $10,000?

TBLMF: 50%PFE: 50%
100% PFE50/50100% TBLMF
Portfolio after 10yr
$1799938.22M
Annual income
$1,774,883,347,945.04/yr
Blended yield
98.61%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PFE right now

TBLMF
No analyst data
Altman Z
8.4
Piotroski
6/9
PFE
Analyst Ratings
16
Buy
22
Hold
1
Sell
Consensus: Hold
Price Target
$27.50
-2.1% upside vs current
Range: $24.00 — $35.00
Altman Z
2.0
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

TBLMF buys
0
PFE buys
8
PoliticianChamberTickerTypeAmountDate
Gilbert Cisneros🏢 House$PFE▲ Buy$1,001 - $15,0002026-02-10
Susan M. Collins🏛 Senate$PFE▲ Buy$15,001 - $50,0002026-02-03
James French Hill🏢 House$PFE▼ Sell$100,001 - $250,0002025-12-31
Gilbert Cisneros🏢 House$PFE▼ Sell$1,001 - $15,0002025-12-19
Ro Khanna🏢 House$PFE▼ Sell$1,001 - $15,0002025-09-15
Ro Khanna🏢 House$PFE▼ Sell$1,001 - $15,0002025-09-05
Gilbert Cisneros🏢 House$PFE▼ Sell$1,001 - $15,0002025-08-05
Lisa McClain🏢 House$PFE▲ Buy$1,001 - $15,0002025-07-16
Ron Wyden🏛 Senate$PFE▼ Sell$1,001 - $15,0002025-06-03
Ron Wyden🏛 Senate$PFE▼ Sell$1,001 - $15,0002025-06-03
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricTBLMFPFE
Forward yield13.61%6.13%
Annual dividend / share$2.84$1.72
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100%13.2%
Portfolio after 10y$3599876.40M$49.6K
Annual income after 10y$3,549,766,669,631.37$26,258.71
Total dividends collected$3596515.63M$58.3K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: TBLMF vs PFE ($10,000, DRIP)

YearTBLMF PortfolioTBLMF Income/yrPFE PortfolioPFE Income/yrGap
1← crossover$13,422$2,721.73$9,153$693.39+$4.3KTBLMF
2$21,189$6,828.11$8,593$849.25+$12.6KTBLMF
3$42,822$20,149.11$8,336$1,066.78+$34.5KTBLMF
4$121,930$76,111.19$8,437$1,384.80+$113.5KTBLMF
5$535,547$405,081.69$9,013$1,875.40+$526.5KTBLMF
6$3,898,670$3,325,634.33$10,306$2,680.72+$3.89MTBLMF
7$49,423,743$45,252,166.17$12,820$4,101.38+$49.41MTBLMF
8$1,125,154,894$1,072,271,488.72$17,673$6,826.70+$1125.14MTBLMF
9$46,831,519,082$45,627,603,346.19$27,543$12,591.86+$46831.49MTBLMF
10$3,599,876,395,050$3,549,766,669,631.37$49,560$26,258.71+$3599876.35MTBLMF

TBLMF vs PFE: Complete Analysis 2026

TBLMFStock

Tiger Brands Limited engages in the manufacture, marketing, and distribution of consumer goods primarily in South Africa. The company offers baby care products under the Purity brand; bakeries under the Albany and Tinkies brands; and culinary fruit veg products under the Crosse & Blackwell, Benny, All Gold, Spray and Cook, Ice Cap, KOO, Colman's, Black Cat, Mrs H.S. Ball's Chutney, and Hugo's brands. It also provides home care products under the Airoma, Bio Classic, Bio Crystal, Doom, Jeyes, and Peaceful Sleep brands; milling products under the Golden Cloud and Ace brands; rice pasta under the Fatti's and Moni's, Cresta, Tastic, and Aunt Caroline brands; and superfoods under the Ace, Jungle, King Korn, and Morvite brands. In addition, the company provides personal care products under the Dolly Varden, Kair, gill, Lemon Lite, No Hair, Perfect Touch, Protein Feed, Status, and Ingram's brands; and snacks, treats, and beverages under the Beacon, Maynards, Hall's, Sparkles, All Sorts, Oros, Jelly Tots, fizzer, Fizz Pop, Smoothies, Rose's, and Energade brands. Further, it provides out of home solutions and product offerings in various pack formats to franchised restaurant groups, hotel groups, catering groups, airlines, institutions, independent restaurants and coffee shops, independent hotels, game reserves, lodges, and bed and breakfast establishments; and product solutions for the establishment cleaning, pest control, and room air refreshing. The company also exports its products to approximately 25 countries in Africa. Tiger Brands Limited was founded in 1920 and is headquartered in Bryanston, South Africa.

Full TBLMF Calculator →

PFEHealthcare

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Full PFE Calculator →
📬

Get this TBLMF vs PFE comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

TBLMF vs SCHDTBLMF vs JEPITBLMF vs OTBLMF vs KOTBLMF vs MAINTBLMF vs JNJTBLMF vs MRKTBLMF vs ABBV

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.